US6030776A
(en)
*
|
1990-06-11 |
2000-02-29 |
Nexstar Pharmaceuticals, Inc. |
Parallel SELEX
|
US5723289A
(en)
*
|
1990-06-11 |
1998-03-03 |
Nexstar Pharmaceuticals, Inc. |
Parallel selex
|
US20030125270A1
(en)
*
|
2000-12-18 |
2003-07-03 |
Lawrence Blatt |
Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection
|
US20040127446A1
(en)
*
|
1992-05-14 |
2004-07-01 |
Lawrence Blatt |
Oligonucleotide mediated inhibition of hepatitis B virus and hepatitis C virus replication
|
US20070160581A1
(en)
*
|
1994-04-29 |
2007-07-12 |
Cytogenix, Inc. |
Production of ssDNA in vivo
|
US6048698A
(en)
*
|
1994-09-20 |
2000-04-11 |
Nexstar Pharmaceuticals, Inc. |
Parallel SELEX™
|
GB9519299D0
(en)
*
|
1995-09-21 |
1995-11-22 |
Farrar Gwyneth J |
Genetic strategy
|
US20040220128A1
(en)
*
|
1995-10-26 |
2004-11-04 |
Sirna Therapeutics, Inc. |
Nucleic acid based modulation of female reproductive diseases and conditions
|
US20040142895A1
(en)
*
|
1995-10-26 |
2004-07-22 |
Sirna Therapeutics, Inc. |
Nucleic acid-based modulation of gene expression in the vascular endothelial growth factor pathway
|
US20040102389A1
(en)
*
|
1995-10-26 |
2004-05-27 |
Ribozyme Pharmaceuticals, Inc. |
Nucleic acid-mediated treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)
|
US20030069195A1
(en)
*
|
1996-03-01 |
2003-04-10 |
Farrar Gwenyth Jane |
Suppression of polymorphic alleles
|
US20040234999A1
(en)
*
|
1996-04-02 |
2004-11-25 |
Farrar Gwenyth Jane |
Genetic suppression and replacement
|
GB9606961D0
(en)
*
|
1996-04-02 |
1996-06-05 |
Farrar Gwyneth J |
Genetic strategy III
|
US8551970B2
(en)
|
1996-04-02 |
2013-10-08 |
Optigen Patents Limited |
Genetic suppression and replacement
|
GB9608540D0
(en)
*
|
1996-04-25 |
1996-07-03 |
Medical Res Council |
Isolation of enzymes
|
CA2264246A1
(en)
*
|
1996-08-26 |
1998-03-05 |
Intelligene Ltd. |
Catalytic nucleic acid and its medical use
|
JP2002514913A
(ja)
*
|
1996-12-19 |
2002-05-21 |
エール ユニバーシティ |
生反応性アロステリックポリヌクレオチド
|
US6057156A
(en)
*
|
1997-01-31 |
2000-05-02 |
Robozyme Pharmaceuticals, Inc. |
Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
|
IL120714A0
(en)
*
|
1997-04-21 |
1997-08-14 |
Intelligene Ltd |
Continuous in vitro evolution of oligonucleotides
|
JP4203126B2
(ja)
*
|
1997-04-29 |
2008-12-24 |
ザ スクリップス リサーチ インスティテュート |
酵素dna分子
|
EP1030913A2
(de)
*
|
1997-09-22 |
2000-08-30 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Katalytische nukleinsäuren mit endonuklease aktivität
|
IL138126A0
(en)
*
|
1998-03-05 |
2001-10-31 |
Johnson & Johnson Res Pty Ltd |
Zymogenic nucleic acid detection methods and related molecules and kits
|
WO1999050452A1
(en)
*
|
1998-03-27 |
1999-10-07 |
Johnson & Johnson Research Pty. Limited |
Catalytic nucleic acid-based diagnostic methods
|
AU3751299A
(en)
|
1998-04-20 |
1999-11-08 |
Ribozyme Pharmaceuticals, Inc. |
Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
|
US6525185B1
(en)
|
1998-05-07 |
2003-02-25 |
Affymetrix, Inc. |
Polymorphisms associated with hypertension
|
AU5298499A
(en)
*
|
1998-08-13 |
2000-03-06 |
Johnson & Johnson Research Pty. Limited |
Dnazymes and methods for treating restenosis
|
AU5298699A
(en)
*
|
1998-08-13 |
2000-03-06 |
Johnson & Johnson Research Pty. Limited |
Dnazymes and methods for treating hpv-related disorders
|
EP1117762A4
(de)
|
1998-09-29 |
2004-02-25 |
Gamida Cell Ltd |
Verfahren zur kontrolle der proliferation und differenzierung von stammzellen und vorläuferzellen
|
AUPP810399A0
(en)
*
|
1999-01-11 |
1999-02-04 |
Unisearch Limited |
Catalytic molecules
|
US20040235107A1
(en)
*
|
1999-01-29 |
2004-11-25 |
Ramot At Tel Aviv University Ltd. |
Biosynthesis of TA antibiotic
|
DE19915141C2
(de)
*
|
1999-03-26 |
2002-11-21 |
Artus Ges Fuer Molekularbiolog |
Detektion von Nucleinsäure-Amplifikaten
|
JP2002541822A
(ja)
*
|
1999-04-14 |
2002-12-10 |
エム ユー エス シー ファンデーション フォー リサーチ ディベロップメント |
組織特異的および病原体特異的毒性物質ならびにリボザイム
|
IL130606A0
(en)
*
|
1999-06-23 |
2000-06-01 |
Intelligene Ltd |
An array of nucleic acid sequence
|
AUPQ201499A0
(en)
*
|
1999-08-04 |
1999-08-26 |
Unisearch Limited |
Treatment of inflammatory and malignant diseases
|
US7668658B2
(en)
|
1999-10-13 |
2010-02-23 |
Sequenom, Inc. |
Methods for generating databases and databases for identifying polymorphic genetic markers
|
AUPQ367699A0
(en)
*
|
1999-10-26 |
1999-11-18 |
Unisearch Limited |
Treatment of cancer
|
US6613516B1
(en)
*
|
1999-10-30 |
2003-09-02 |
Affymetrix, Inc. |
Preparation of nucleic acid samples
|
WO2001049709A1
(en)
*
|
2000-01-03 |
2001-07-12 |
Ramot University Authority For Applied Research & Industrial Development Ltd. |
Glycogen synthase kinase-3 inhibitors
|
WO2001062983A1
(en)
*
|
2000-02-24 |
2001-08-30 |
Phylos, Inc. |
Improved methods for generating catalytic proteins
|
US20040009510A1
(en)
*
|
2000-03-06 |
2004-01-15 |
Scott Seiwert |
Allosteric nucleic acid sensor molecules
|
US20020102694A1
(en)
*
|
2000-03-31 |
2002-08-01 |
Ronald Breaker |
Nucleozymes with endonuclease activity
|
EP1702983A3
(de)
|
2000-04-13 |
2007-01-10 |
Medical University of South Carolina |
Gewebespezifische und pathogenspezifische giftige Verbindungen, Ribozyme, DNAzyme und Antisenseolinukleotide sowie Anwendungen dafür
|
US6706474B1
(en)
|
2000-06-27 |
2004-03-16 |
Board Of Trustees Of The University Of Illinois |
Nucleic acid enzyme biosensors for ions
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
US20030114410A1
(en)
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
US8568766B2
(en)
|
2000-08-24 |
2013-10-29 |
Gattadahalli M. Anantharamaiah |
Peptides and peptide mimetics to treat pathologies associated with eye disease
|
US7312325B2
(en)
*
|
2000-09-26 |
2007-12-25 |
Duke University |
RNA aptamers and methods for identifying the same
|
EP1326892A2
(de)
|
2000-10-12 |
2003-07-16 |
University of Rochester |
Zusammensetzungen die die proliferation von krebszellen hemmen
|
CA2442092A1
(en)
*
|
2001-03-26 |
2002-10-17 |
Ribozyme Pharmaceuticals, Inc. |
Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
|
US20040063922A1
(en)
*
|
2001-04-17 |
2004-04-01 |
Conrad Charles A. |
Methods and compositions for catalytic DNA exchange in a sequence specific manner
|
US20040198682A1
(en)
*
|
2001-11-30 |
2004-10-07 |
Mcswiggen James |
RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (siNA)
|
US20040006035A1
(en)
*
|
2001-05-29 |
2004-01-08 |
Dennis Macejak |
Nucleic acid mediated disruption of HIV fusogenic peptide interactions
|
US20050288242A1
(en)
*
|
2001-05-18 |
2005-12-29 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of RAS gene expression using short interfering nucleic acid (siNA)
|
US20050267058A1
(en)
*
|
2001-05-18 |
2005-12-01 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (sINA)
|
US20050080031A1
(en)
*
|
2001-05-18 |
2005-04-14 |
Sirna Therapeutics, Inc. |
Nucleic acid treatment of diseases or conditions related to levels of Ras, HER2 and HIV
|
ATE482227T1
(de)
*
|
2001-05-25 |
2010-10-15 |
Univ Duke |
Modulatoren pharmakologischer mittel
|
EP1390472A4
(de)
*
|
2001-05-29 |
2004-11-17 |
Sirna Therapeutics Inc |
Nukleinsäurebehandlung von krankheiten oder leiden im zusammenhang mit ras-, her2- und hiv-niveaus
|
US7378432B2
(en)
*
|
2001-09-14 |
2008-05-27 |
Tel Aviv University Future Technology Development L.P. |
Glycogen synthase kinase-3 inhibitors
|
WO2003051314A2
(en)
|
2001-12-18 |
2003-06-26 |
Medallion Biomedical, Llc |
Antibiotic compounds
|
IL152904A0
(en)
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
WO2003062404A1
(en)
|
2002-01-25 |
2003-07-31 |
Gamida-Cell Ltd. |
Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
WO2003065997A2
(en)
|
2002-02-06 |
2003-08-14 |
Vicor Technologies, Inc. |
Anti-infarction molecules
|
US20050042632A1
(en)
*
|
2002-02-13 |
2005-02-24 |
Sirna Therapeutics, Inc. |
Antibodies having specificity for nucleic acids
|
US7071311B2
(en)
*
|
2002-02-13 |
2006-07-04 |
Sirna Therapeutics, Inc. |
Antibodies having specificity for 2′-C-allyl nucleic acids
|
JP2005517409A
(ja)
|
2002-02-15 |
2005-06-16 |
マクマスター ユニヴァーシティー |
デオキシリボザイム
|
WO2003106476A1
(en)
*
|
2002-02-20 |
2003-12-24 |
Sirna Therapeutics, Inc |
Nucleic acid mediated inhibition of enterococcus infection and cytolysin toxin activity
|
US20060035810A1
(en)
*
|
2002-03-18 |
2006-02-16 |
Shears Stephen B |
Regulation of ins(3456)p4 signalling by a reversible kinase phosphatase and methods and compositions related thereto
|
US6890719B2
(en)
*
|
2002-05-10 |
2005-05-10 |
The Board Of Trustess Of The University Of Illinois |
Fluorescence based biosensor
|
US7534560B2
(en)
*
|
2002-05-10 |
2009-05-19 |
The Board Of Trustees Of The University Of Illinois |
Simple catalytic DNA biosensors for ions based on color changes
|
US20030224435A1
(en)
*
|
2002-05-16 |
2003-12-04 |
Scott Seiwert |
Detection of abused substances and their metabolites using nucleic acid sensor molecules
|
WO2003106617A2
(en)
*
|
2002-06-12 |
2003-12-24 |
Tel Aviv Medical Center Research Development Fund |
Oligonucleotides antibodies and kits including same for treating prostate cancer and determining predisposition thereto
|
US7704965B2
(en)
*
|
2002-06-26 |
2010-04-27 |
The Penn State Research Foundation |
Methods and materials for treating human papillomavirus infections
|
AU2003261264B2
(en)
|
2002-07-25 |
2008-12-11 |
Archemix Corp. |
Regulated aptamer therapeutics
|
CA2495478A1
(en)
|
2002-08-05 |
2004-02-12 |
University Of Rochester |
Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
|
WO2004027035A2
(en)
*
|
2002-09-20 |
2004-04-01 |
Yale University |
Riboswitches, methods for their use, and compositions for use with riboswitches.
|
WO2004041197A2
(en)
*
|
2002-11-01 |
2004-05-21 |
Case Western Reserve University |
Methods of inhibiting glial scar formation
|
JP4786904B2
(ja)
|
2002-11-27 |
2011-10-05 |
セクエノム,インコーポレイティド |
配列変化検出及び発見用の断片化をベースとする方法及びシステム
|
US7491699B2
(en)
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
AU2003286411A1
(en)
|
2002-12-12 |
2004-06-30 |
Tel Aviv University Future Technology Development L.P. |
Glycogen synthase kinase-3 inhibitors
|
WO2004060791A1
(en)
|
2003-01-07 |
2004-07-22 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures encapsulating a foreign material and method of manufacturing same
|
US20060241130A1
(en)
*
|
2003-01-31 |
2006-10-26 |
Ehud Keinan |
Anti-inflammatory compositions and uses thereof
|
EP1597350B1
(de)
|
2003-02-27 |
2015-04-08 |
Yeda Research And Development Co., Ltd. |
Zur behandlung und zum nachweis einer influenzavirusinfektion geeignete nukleinsäuremoleküle, und diese enthaltende zusammensetzungen
|
WO2004079325A2
(en)
*
|
2003-03-07 |
2004-09-16 |
Mcmaster University |
Ph dependent signaling dna enzymes
|
US7612185B2
(en)
*
|
2003-03-07 |
2009-11-03 |
The Board Of Trustees Of The University Of Illinois |
Nucleic acid biosensors
|
US20050020526A1
(en)
*
|
2003-06-03 |
2005-01-27 |
Cytogenix, Inc. |
Oligodeoxynucleotide intervention for prevention and treatment of sepsis
|
US20040248101A1
(en)
*
|
2003-06-03 |
2004-12-09 |
Cytogenix, Inc. |
Identification of novel antibacteria agents by screening the single-stranded DNA expression library
|
US7498428B2
(en)
*
|
2003-06-19 |
2009-03-03 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
US8129514B2
(en)
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
IL161903A0
(en)
*
|
2003-07-17 |
2005-11-20 |
Gamida Cell Ltd |
Ex vivo progenitor and stem cell expansion for usein the treatment of disease of endodermally- deri ved organs
|
US20050042212A1
(en)
*
|
2003-07-24 |
2005-02-24 |
Nanda Steven A. |
Method of reducing CRF receptor mRNA
|
US9394565B2
(en)
|
2003-09-05 |
2016-07-19 |
Agena Bioscience, Inc. |
Allele-specific sequence variation analysis
|
WO2005027901A1
(en)
*
|
2003-09-25 |
2005-03-31 |
Tel Aviv University Future Technology Development L.P. |
Compositions and methods using same for treating amyloid-associated diseases
|
US7625707B2
(en)
*
|
2003-10-02 |
2009-12-01 |
Ramot At Tel Aviv University Ltd. |
Antibacterial agents and methods of identifying and utilizing same
|
IL158599A0
(en)
*
|
2003-10-26 |
2004-05-12 |
Yeda Res & Dev |
Methods of modulating hematopoiesis
|
US7485419B2
(en)
*
|
2004-01-13 |
2009-02-03 |
The Board Of Trustees Of The University Of Illinois |
Biosensors based on directed assembly of particles
|
GB0402249D0
(en)
|
2004-02-02 |
2004-03-03 |
Idi Technologies Ltd |
Brush
|
US20060019914A1
(en)
*
|
2004-02-11 |
2006-01-26 |
University Of Tennessee Research Foundation |
Inhibition of tumor growth and invasion by anti-matrix metalloproteinase DNAzymes
|
EP1727911B1
(de)
|
2004-03-26 |
2013-01-23 |
Sequenom, Inc. |
Basenspezifische spaltung methylierungsspezifischer amplifikationsprodukte in kombination mit massenanalyse
|
SG152262A1
(en)
*
|
2004-04-22 |
2009-05-29 |
Regado Biosciences Inc |
Improved modulators of coagulation factors
|
US8568637B2
(en)
|
2004-08-02 |
2013-10-29 |
Ramot At Tel-Aviv University Ltd. |
Method of forming a fiber made of peptide nanostructures
|
ATE539745T1
(de)
|
2004-08-19 |
2012-01-15 |
Univ Tel Aviv Future Tech Dev |
Zusammensetzungen zur behandlung von amyloid- assoziierten erkrankungen
|
WO2006027780A2
(en)
|
2004-09-08 |
2006-03-16 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
|
WO2006030442A2
(en)
|
2004-09-16 |
2006-03-23 |
Gamida-Cell Ltd. |
Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
|
US20060094026A1
(en)
*
|
2004-11-03 |
2006-05-04 |
Yi Lu |
Nucleic acid enzyme light-up sensor utilizing invasive DNA
|
WO2006055292A2
(en)
*
|
2004-11-04 |
2006-05-26 |
University Of Medicine And Dentistry Of New Jersey |
Single protein production in living cells facilitated by a messenger rna interferase
|
CA2588087A1
(en)
*
|
2004-11-15 |
2006-05-18 |
Obe Therapy Biotechnology S.A.S. |
Methods of reducing body fat
|
US20060166222A1
(en)
*
|
2005-01-21 |
2006-07-27 |
Yi Lu |
Nucleic acid enzyme ligation sensor
|
US8129124B2
(en)
|
2005-02-02 |
2012-03-06 |
The Uab Research Foundation |
Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists
|
NZ561883A
(en)
|
2005-03-23 |
2010-11-26 |
Genmab As |
Antibodies against CD38 for treatment of multiple myeloma
|
US20070072205A1
(en)
*
|
2005-06-09 |
2007-03-29 |
Yi Lu |
Nanomaterial error correction
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
JP5383186B2
(ja)
|
2005-07-07 |
2014-01-08 |
イッサム リサーチ ディベロプメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム リミテッド |
H19をダウンレギュレートする核酸薬剤、及びそれを使用する方法
|
US20090239933A1
(en)
*
|
2005-08-01 |
2009-09-24 |
Carolina Alfieri |
Hepatitis c antivirals
|
US7892734B2
(en)
*
|
2005-08-11 |
2011-02-22 |
The Board Of Trustees Of The University Of Illinois |
Aptamer based colorimetric sensor systems
|
ES2937245T3
(es)
|
2005-08-23 |
2023-03-27 |
Univ Pennsylvania |
ARN que contiene nucleósidos modificados y métodos de uso del mismo
|
EP1934244A2
(de)
*
|
2005-10-06 |
2008-06-25 |
Emthrax LLC |
Verfahren und zusammensetzungen in verbindung mit milzbrandsporen-glycoproteinen als impfstoffe
|
US8394946B2
(en)
*
|
2005-10-07 |
2013-03-12 |
Speedx Pty Ltd |
Multicomponent nucleic acid enzymes and methods for their use
|
WO2007043048A2
(en)
|
2005-10-11 |
2007-04-19 |
Ramot At Tel Aviv University Ltd. |
Self-assembled fmoc-ff hydrogels
|
EP1934348B1
(de)
*
|
2005-10-11 |
2018-05-02 |
Ben-Gurion University Of The Negev Research And Development Authority |
Zusammensetzung zum silencing der expression von vdac1 und verwendungen davon
|
US8080534B2
(en)
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
CA2625891A1
(en)
|
2005-10-14 |
2007-04-26 |
Carlton D. Donald |
Inhibition of pax2 by defb1 induction as a therapy for cancer
|
US7879212B2
(en)
*
|
2005-11-03 |
2011-02-01 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructure-coated electrodes
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
WO2007100412A2
(en)
*
|
2005-12-21 |
2007-09-07 |
Yale University |
Methods and compositions related to the modulation of riboswitches
|
CN100562342C
(zh)
*
|
2006-01-17 |
2009-11-25 |
奥林格斯技术有限公司 |
防治流感病毒感染的寡核苷酸药物
|
US7799554B2
(en)
*
|
2006-03-16 |
2010-09-21 |
The Board Of Trustees Of The University Of Illinois |
Lateral flow devices
|
US8097596B2
(en)
*
|
2006-06-30 |
2012-01-17 |
Lakewood-Amedex, Inc. |
Compositions and methods for the treatment of muscle wasting
|
JP2010502752A
(ja)
*
|
2006-09-11 |
2010-01-28 |
イェール ユニバーシティー |
リシンリボスイッチ、リシンリボスイッチを用いた構造に基づく化合物設計、ならびにリシンリボスイッチを用いた使用のための方法および組成物
|
CA2981308C
(en)
|
2006-09-21 |
2020-12-22 |
University Of Rochester |
Compositions and methods related to protein displacement therapy for myotonic dystrophy
|
KR20090098960A
(ko)
*
|
2006-10-06 |
2009-09-18 |
존슨 앤드 존슨 리서치 피티와이 리미티드 |
분자 스위치 및 이의 이용 방법
|
WO2008136852A2
(en)
|
2006-11-01 |
2008-11-13 |
University Of Rochester |
Methods and compositions related to the structure and function of apobec3g
|
DE602007014389D1
(de)
|
2006-11-01 |
2011-06-16 |
Medical Res And Infrastructure Fund Of The Tel Aviv |
Adipozytenspezifische konstrukte und verfahren zur hemmung der expression von blutplättchen-typ-12-lipoxygenase
|
BRPI0720038A2
(pt)
|
2006-12-11 |
2013-12-24 |
Univ Utah Res Found |
Métodos para inibir a permeabilidade vascular em tecido, para triar ou avaliar um agente que inibe a permeabilidade vascular, para tratar ou prevenir a síndrome da angústia respiratória, a retinopatia de prematuridade, a retinopatia diabética e a degeneração macular úmida em um indivíduo, para tratar indivíduos com sugestões repulsivas ou miméticos e para promover a angiogênese em um tecido, polipeptídeo isolado, ácido nucleico isolado, e, vetor
|
CA2675967A1
(en)
*
|
2007-01-16 |
2008-07-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusale M |
Nucleic acid constructs and methods for specific silencing of h19
|
WO2008089248A2
(en)
*
|
2007-01-19 |
2008-07-24 |
The Board Of Trustees Of The University Of Illinois |
Amphiphilic substances and triggered liberation from lipid vesicles
|
WO2008093331A1
(en)
*
|
2007-01-29 |
2008-08-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Antibody conjugates for circumventing multi-drug resistance
|
AU2008235256B2
(en)
*
|
2007-04-05 |
2014-05-15 |
Speedx Pty Ltd |
Nucleic acid enzymes and complexes and methods for their use
|
US8058415B2
(en)
|
2007-04-24 |
2011-11-15 |
The Board Of Trustees Of The University Of Illinois |
Aptamer- and nucleic acid enzyme-based systems for simultaneous detection of multiple analytes
|
WO2008150884A1
(en)
*
|
2007-05-29 |
2008-12-11 |
Yale University |
Methods and compositions related to riboswitches that control alternative splicing and rna processing
|
EP2426219A1
(de)
*
|
2007-05-29 |
2012-03-07 |
Yale University |
Riboswitches sowie Verfahren und Zusammensetzungen zur Verwendung von und mit Riboswitches
|
WO2008153063A1
(ja)
*
|
2007-06-11 |
2008-12-18 |
Dai Nippon Printing Co., Ltd. |
細胞培養膜、細胞培養キット、多孔質体、細胞培養膜の製造方法及び多孔質体の製造方法
|
AU2008277257B2
(en)
|
2007-07-15 |
2014-03-06 |
Hillman, Yitzchak Mr |
Disease treatment via antimicrobial peptides or their inhibitors
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
US8409800B2
(en)
*
|
2007-07-16 |
2013-04-02 |
The Board Of Trustees Of The University Of Illinois |
Nucleic acid based fluorescent sensor for copper detection
|
US8568690B2
(en)
*
|
2007-07-31 |
2013-10-29 |
The Board Of Trustees Of The University Of Illinois |
MRI contrast agents and high-throughput screening by MRI
|
CN105330743B
(zh)
*
|
2007-08-02 |
2019-05-28 |
吉利德生物制剂公司 |
Lox和loxl2抑制剂及其应用
|
US8367416B2
(en)
|
2007-08-10 |
2013-02-05 |
The Board Of Trustees Of The University Of Illinois |
Nucleic acid based fluorescent sensor for mercury detection
|
US20100239596A1
(en)
*
|
2007-08-22 |
2010-09-23 |
University Of Southern California |
Grp78 and tumor angiogenesis
|
JP2010537638A
(ja)
|
2007-08-28 |
2010-12-09 |
ユーエービー リサーチ ファウンデーション |
合成アポリポ蛋白質e模倣ポリペプチドおよび使用方法
|
DK2682400T5
(da)
|
2007-08-28 |
2017-11-27 |
Uab Research Foundation |
Syntetiske apolipoprotein E-efterlignende polypeptider og fremgangsmåder til anvendelse
|
US8501912B2
(en)
*
|
2007-12-03 |
2013-08-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Filipil compositions and methods for treating cancer
|
US20090233993A1
(en)
*
|
2008-03-06 |
2009-09-17 |
Burnham Institute For Medical Research |
Compositions and methods for inhibiting gsk3 activity and uses thereof
|
CA2717320A1
(en)
|
2008-03-11 |
2009-09-17 |
Sequenom, Inc. |
Nucleic acid-based tests for prenatal gender determination
|
EP2288922B1
(de)
|
2008-05-08 |
2016-08-17 |
University of Utah Research Foundation |
Sensorische rezeptoren für chronische müdigkeit und schmerzen und verwendungen dafür
|
US20100105039A1
(en)
*
|
2008-06-03 |
2010-04-29 |
Yi Lu |
Label-free colorimetric detection
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
US8062893B2
(en)
|
2008-10-10 |
2011-11-22 |
The Board Of Trustees Of The University Of Illinois |
Fluorescent sensor for mercury
|
US20120070443A1
(en)
|
2008-12-02 |
2012-03-22 |
University Of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
EP2808402A3
(de)
|
2008-12-29 |
2015-03-25 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Verfahren zur Vorhersage des Ansprechens auf Interferonbehandlung
|
WO2010080769A2
(en)
|
2009-01-06 |
2010-07-15 |
Arresto Biosciences, Inc. |
Chemotherapeutic methods and compositions
|
DK2414542T3
(da)
|
2009-03-30 |
2017-11-27 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Fremgangsmåder til forudsigelse af klinisk forløb for og behandling af multipel sklerose
|
CA2759201A1
(en)
|
2009-04-01 |
2010-10-07 |
The Medical Research, Infrastructure, And Health Services Fund Of The Te L Aviv Medical Center |
A method of regulating proliferation and differentiation of keratinocyes
|
US20120070449A1
(en)
|
2009-05-28 |
2012-03-22 |
Yeda Research And Development Co. Ltd. |
Methods of treating inflammation
|
WO2011004379A1
(en)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions and methods for treating cancer
|
BR112012008078A2
(pt)
|
2009-08-21 |
2017-07-04 |
Beeologics Inc |
prevenção e cura de doenças de inseto benéfico por meio de moléculas transcritas de planta.
|
JP2013502226A
(ja)
|
2009-08-21 |
2013-01-24 |
ギリアド バイオロジクス,インク. |
リシル酸化酵素及びloxl2由来の触媒ドメイン
|
US9610331B2
(en)
|
2009-09-08 |
2017-04-04 |
Yeda Research And Development Co. Ltd. |
Methods for hematopoietic precursor mobilization
|
US20110060000A1
(en)
|
2009-09-10 |
2011-03-10 |
Maurizio Grimaldi |
Acridine analogs in the treatment of gliomas
|
ES2577017T3
(es)
|
2009-12-22 |
2016-07-12 |
Sequenom, Inc. |
Procedimientos y kits para identificar la aneuploidia
|
CN105622757A
(zh)
|
2010-02-04 |
2016-06-01 |
吉联亚生物科技有限公司 |
结合赖氨酰氧化酶样2(loxl2)的抗体和其使用方法
|
US20110207789A1
(en)
|
2010-02-19 |
2011-08-25 |
Ye Fang |
Methods related to casein kinase ii (ck2) inhibitors and the use of purinosome-disrupting ck2 inhibitors for anti-cancer therapy agents
|
WO2011107939A1
(en)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting efficacy of an anti-vegfa treatment for solid tumors
|
US9453237B2
(en)
|
2010-03-09 |
2016-09-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Organism with altered carotenoid content and method of producing same
|
US9518988B2
(en)
|
2010-04-18 |
2016-12-13 |
Yeda Research And Development Co. Ltd. |
Antibodies and methods of using same for treating ErbB/ErbB ligands associated diseases
|
US9187787B2
(en)
|
2010-06-16 |
2015-11-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of diagnosing and treating cancer
|
US8815156B2
(en)
|
2010-07-19 |
2014-08-26 |
Andalyze, Inc. |
Sensor housing and reagent chemistry
|
EP3578205A1
(de)
|
2010-08-06 |
2019-12-11 |
ModernaTX, Inc. |
Pharmazeutische zusammensetzungen enthaltenbearbeitete nukleinsäuren und ihre medizinische verwendung
|
WO2012032522A1
(en)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Thiamine pyrophosphate (tpp) riboswitch mutants producing vitamin b1 enriched food and feed crops
|
US9051606B2
(en)
|
2010-09-10 |
2015-06-09 |
Qiagen Gaithersburg, Inc. |
Methods and compositions for nucleic acid detection
|
CN103210082A
(zh)
|
2010-09-15 |
2013-07-17 |
雷蒙特亚特特拉维夫大学有限公司 |
扩增胰岛β细胞和使其再分化的方法
|
US8871737B2
(en)
|
2010-09-22 |
2014-10-28 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
SG190679A1
(en)
|
2010-10-01 |
2013-07-31 |
Jason Schrum |
Engineered nucleic acids and methods of use thereof
|
EP2627766B1
(de)
|
2010-10-17 |
2016-05-25 |
Yeda Research and Development Co. Ltd. |
Verfahren und zusammensetzungen zur behandlung von insulinassoziierten erkrankungen
|
WO2012095843A1
(en)
|
2011-01-13 |
2012-07-19 |
Yeda Research And Development Co. Ltd. |
Organisms with altered steroidal saponin and steroidal alkaloid levels and methods for producing same
|
WO2012101599A2
(en)
|
2011-01-27 |
2012-08-02 |
Ramot At Tel-Aviv University Ltd. |
Glycogen synthase kinase-3 inhibitors
|
EP2668200B1
(de)
|
2011-01-27 |
2017-03-15 |
Ramot at Tel-Aviv University Ltd. |
Inhibitoren vom lycogen-synthase-kinase-3
|
AU2012236099A1
(en)
|
2011-03-31 |
2013-10-03 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
EP2702168B1
(de)
|
2011-04-29 |
2018-01-17 |
Sequenom, Inc. |
Quantifizierung einer minderheitsvariante einer nukleinsäure
|
ES2670596T3
(es)
|
2011-06-14 |
2018-05-31 |
Yeda Research And Development Co. Ltd. |
Terapia de combinación para prevenir la formación del DCIS y la progresión hasta cáncer de mama
|
WO2013021389A2
(en)
|
2011-08-09 |
2013-02-14 |
Yeda Research And Development Co.Ltd. |
Downregulation of mir-7 for promotion of beta cell differentiation and insulin production
|
SG11201400464QA
(en)
*
|
2011-09-09 |
2014-06-27 |
Speedx Pty Ltd |
Nucleic acid enzyme substrates
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
SG11201401196WA
(en)
|
2011-10-03 |
2014-05-29 |
Moderna Therapeutics Inc |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
WO2013061328A2
(en)
|
2011-10-27 |
2013-05-02 |
Yeda Research And Development Co. Ltd. |
Method of treating cancer
|
EP2782930B1
(de)
|
2011-11-27 |
2018-07-11 |
Yeda Research and Development Co. Ltd. |
Verfahren zur angiogeneseregulierung und zusammensetzungen dafür
|
AU2012352180A1
(en)
|
2011-12-16 |
2014-07-31 |
Moderna Therapeutics, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
WO2013096680A1
(en)
|
2011-12-22 |
2013-06-27 |
Alios Biopharma, Inc. |
Substituted phosphorothioate nucleotide analogs
|
CN104204192A
(zh)
|
2012-02-13 |
2014-12-10 |
加米达细胞有限公司 |
间充质干细胞调理的基质及其产生和使用方法
|
WO2013124816A2
(en)
|
2012-02-22 |
2013-08-29 |
Brainstem Biotec Ltd. |
Generation of neural stem cells and motor neurons
|
EP4155401A1
(de)
|
2012-03-02 |
2023-03-29 |
Sequenom, Inc. |
Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
|
JP2015516371A
(ja)
|
2012-03-07 |
2015-06-11 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
キエシンスルフヒドリルオキシダーゼ(qsox1)を阻害するための組成物および該組成物の使用
|
EP2828277A1
(de)
|
2012-03-21 |
2015-01-28 |
Vertex Pharmaceuticals Incorporated |
Feste formen eines thiophosphoramidat-nucleotid-prodrugs
|
WO2013142157A1
(en)
|
2012-03-22 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
US9192651B2
(en)
|
2012-04-02 |
2015-11-24 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of secreted proteins
|
US9303079B2
(en)
|
2012-04-02 |
2016-04-05 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
AU2013290102B2
(en)
|
2012-07-13 |
2018-11-15 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
US9597380B2
(en)
|
2012-11-26 |
2017-03-21 |
Modernatx, Inc. |
Terminally modified RNA
|
IN2014MN02655A
(de)
|
2012-11-29 |
2015-08-21 |
Yeda Res & Dev |
|
EP3597774A1
(de)
|
2013-03-13 |
2020-01-22 |
Sequenom, Inc. |
Primer zur analyse der dna-methylierung
|
US20160032316A1
(en)
|
2013-03-14 |
2016-02-04 |
The Trustees Of The University Of Pennsylvania |
Purification and Purity Assessment of RNA Molecules Synthesized with Modified Nucleosides
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
CA2909380A1
(en)
|
2013-04-21 |
2014-10-30 |
Yeda Research And Development Co. Ltd. |
Agents for downregulation of the activity and/or amount of bcl-xl and/or bcl-w
|
US10806119B2
(en)
|
2013-06-05 |
2020-10-20 |
Yeda Research And Development Co. Ltd. |
Plant with altered content of steroidal alkaloids
|
US10100322B2
(en)
|
2013-06-05 |
2018-10-16 |
Yeda Research And Development Co. Ltd. |
Plant with altered content of steroidal glycoalkaloids
|
WO2014207743A2
(en)
|
2013-06-24 |
2014-12-31 |
Ramot At Tel-Aviv University Ltd. |
Glycogen synthase kinase-3 inhibitors
|
CN105451726B
(zh)
|
2013-06-25 |
2021-03-16 |
沃尔特和伊利莎豪医学研究所 |
治疗细胞内感染的方法
|
EP3052106A4
(de)
|
2013-09-30 |
2017-07-19 |
ModernaTX, Inc. |
Polynukleotide zur codierung immunmodulierender polypeptide
|
MX2016004249A
(es)
|
2013-10-03 |
2016-11-08 |
Moderna Therapeutics Inc |
Polinulcleotidos que codifican el receptor de lipoproteina de baja densidad.
|
US20170042893A1
(en)
|
2014-02-03 |
2017-02-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Use of casein kinase i inhibitors for depleting stem cells
|
CN106715695B
(zh)
|
2014-02-05 |
2020-07-31 |
耶达研究及发展有限公司 |
用于治疗和诊断的微rna和包含所述微rna的组合物
|
US11365447B2
(en)
|
2014-03-13 |
2022-06-21 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
WO2015186129A1
(en)
|
2014-06-02 |
2015-12-10 |
Technion Research & Development Foundation Limited. |
Compositions and methods of selectively inhibiting irp1 and treating inflammation
|
CN108064274A
(zh)
|
2014-07-30 |
2018-05-22 |
耶达研究及发展有限公司 |
用于培养多能干细胞的培养基
|
JP7081923B2
(ja)
|
2014-07-31 |
2022-06-07 |
ユーエイビー リサーチ ファンデーション |
アポe模倣ペプチド及び血漿コレステロールを取り除くためのより高い効果
|
WO2016030899A1
(en)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Methods of treating amyotrophic lateral scleroses
|
WO2016079736A2
(en)
|
2014-11-17 |
2016-05-26 |
Yeda Research And Development Co. Ltd. |
Methods of treating diseases related to mitochondrial function
|
WO2016079527A1
(en)
|
2014-11-19 |
2016-05-26 |
Tetralogic Birinapant Uk Ltd |
Combination therapy
|
WO2016097773A1
(en)
|
2014-12-19 |
2016-06-23 |
Children's Cancer Institute |
Therapeutic iap antagonists for treating proliferative disorders
|
US20170369556A1
(en)
|
2014-12-23 |
2017-12-28 |
Ralph A. Tripp |
RECOMBINANT CELLS COMPRISING miRNA MIMICS
|
EP3261612A1
(de)
|
2015-02-26 |
2018-01-03 |
Yeda Research and Development Co. Ltd |
Verfahren zur förderung des haarwuchses
|
CA2977607A1
(en)
|
2015-02-26 |
2016-09-01 |
Jacob Schneiderman |
Methods and compositions relating to leptin antagonists
|
WO2016162870A1
(en)
|
2015-04-07 |
2016-10-13 |
Ilana Nathan |
Compositions for treating and/or preventing cell or tissue necrosis specifically targeting cathepsin c and/or cela1 and/or cela3a and/or structurally related enzymes thereto
|
EP3294280A1
(de)
|
2015-05-11 |
2018-03-21 |
Yeda Research and Development Co., Ltd. |
Citrinhemmer zur behandlung von krebs
|
WO2016185457A1
(en)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Methods of promoting lymphangiogenesis
|
US20180221393A1
(en)
|
2015-08-03 |
2018-08-09 |
Biokine Therapeutics Ltd. |
Cxcr4 binding agents for treatment of diseases
|
IL289849B2
(en)
|
2015-11-10 |
2024-01-01 |
Nat Inst Biotechnology Negev Ltd |
Means and methods for reducing the tumorigenicity of cancer stem cells
|
EP3400068A1
(de)
|
2016-01-06 |
2018-11-14 |
Yeda Research and Development Co., Ltd. |
Zusammensetzungen und verfahren zur behandlung von bösartigen, autoimmun- und entzündungserkrankungen
|
US20190216891A1
(en)
|
2016-03-06 |
2019-07-18 |
Yeda Research And Development Co., Ltd. |
Method for modulating myelination
|
CA3018305A1
(en)
|
2016-03-30 |
2017-10-05 |
Regentis Biomaterials Ltd. |
Treatments utilizing a polymer-protein conjugate
|
CA3027272C
(en)
*
|
2016-07-13 |
2022-06-21 |
The Procter & Gamble Company |
Bacillus cibi dnase variants and uses thereof
|
CN110087665A
(zh)
|
2016-08-03 |
2019-08-02 |
H·李·莫菲特癌症中心与研究所公司 |
Tlr9靶向治疗
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
IL250538A0
(en)
|
2017-02-09 |
2017-03-30 |
Yeda Res & Dev |
Metabolizing glycoalkaloid enzymes (games) and their uses
|
EP3638215A4
(de)
|
2017-06-15 |
2021-03-24 |
Modernatx, Inc. |
Rna-formulierungen
|
AU2018292104A1
(en)
|
2017-06-30 |
2019-12-19 |
Codexis, Inc. |
T7 RNA polymerase variants
|
KR20200023455A
(ko)
|
2017-06-30 |
2020-03-04 |
코덱시스, 인코포레이티드 |
T7 rna 폴리머라제 변이체
|
US11555192B2
(en)
|
2017-07-27 |
2023-01-17 |
The National Institute for Biotechnology in the Negev Ltd. |
SMAC/Diablo inhibitors useful for treating cancer
|
JP7275111B2
(ja)
|
2017-08-31 |
2023-05-17 |
モデルナティエックス インコーポレイテッド |
脂質ナノ粒子の生成方法
|
WO2019051355A1
(en)
|
2017-09-08 |
2019-03-14 |
Ohio State Innovation Foundation |
NEW MICROARN INHIBITOR THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with enhanced properties
|
CA3111386A1
(en)
|
2018-09-06 |
2020-03-12 |
Yeda Research And Development Co. Ltd. |
Cellulose-synthase-like enzymes and uses thereof
|
IL265841A
(en)
|
2019-04-03 |
2020-10-28 |
Yeda Res & Dev |
A plant that expresses animal milk proteins
|
WO2021019526A1
(en)
|
2019-07-29 |
2021-02-04 |
Yeda Research And Development Co. Ltd. |
Methods of treating and diagnosing lung cancer
|
EP4267742A2
(de)
*
|
2020-12-28 |
2023-11-01 |
1E Therapeutics, Ltd. |
Auf p21-mrna abzielende dnazyme
|
IL304047A
(en)
|
2020-12-28 |
2023-08-01 |
1E Therapeutics Ltd |
Silencing target sites in the p21 mRNA sequence
|